Hu D, Chen L, Qu Y, Peng J, Chu B, Shi Ok, Hao Y, Zhong L, Wang M, Qian Z. Oxygen-generating hybrid polymeric nanoparticles with encapsulated doxorubicin and chlorin e6 for trimodal imaging-guided mixed chemo-photodynamic remedy. Theranostics. 2018;8(6):1558–74.
Chen WH, Luo GF, Lei Q, Hong S, Qiu WX, Liu LH, Cheng SX, Zhang XZ. Overcoming the warmth endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal remedy. ACS Nano. 2017;11(2):1419–31.
Xiao H, Qi R, Li T, Awuah SG, Zheng Y, Wei W, Kang X, Music H, Wang Y, Yu Y, Hen MA, Jing X, Yaffe MB, Birrer MJ, Ghoroghchian PP. Maximizing synergistic exercise when combining rnai and platinum-based anticancer brokers. J Am Chem Soc. 2017;139(8):3033–44.
Lee H, Lee Y, Music C, Cho HR, Ghaffari R, Choi TK, Kim KH, Lee YB, Ling D, Lee H, Yu SJ, Choi SH, Hyeon T, Kim DH. An endoscope with built-in clear bioelectronics and theranostic nanoparticles for colon most cancers therapy. Nat Commun. 2015;6:10059.
Feng Q, Zhang Y, Zhang W, Shan X, Yuan Y, Zhang H, Hou L, Zhang Z. Tumor-targeted and multi-stimuli responsive drug supply system for near-infrared gentle induced chemo-phototherapy and photoacoustic tomography. Acta Biomater. 2016;38:129–42.
Zhang Y, Yin Y, Zhang W, Li H, Wang T, Yin H, Solar L, Su C, Zhang Ok, Xu H. Reactive oxygen species scavenging and irritation mitigation enabled by biomimetic Prussian blue analogues boycott atherosclerosis. J Nanobiotechnol. 2021;19(1):161.
Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, Jia Q, Niu G, Huang X, Zhou H, Meng X, Wang P, Lee CS, Zhang W, Han X. A graphene quantum dot photodynamic remedy agent with excessive singlet oxygen technology. Nat Commun. 2014;5:4596.
Kotagiri N, Sudlow GP, Akers WJ, Achilefu S. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nanotechnol. 2015;10(4):370–9.
Li Y, Wen T, Zhao R, Liu X, Ji T, Wang H, Shi X, Shi J, Wei J, Zhao Y, Wu X, Nie G. Localized electrical area of plasmonic nanoplatform enhanced photodynamic tumor remedy. ACS Nano. 2014;8(11):11529–42.
Liang S, Deng X, Chang Y, Solar C, Shao S, Xie Z, Xiao X, Ma P, Zhang H, Cheng Z, Lin J. Clever hole Pt-CuS Janus structure for synergistic catalysis-enhanced sonodynamic and photothermal most cancers remedy. Nano Lett. 2019;19(6):4134–45.
Han X, Huang J, Jing X, Yang D, Lin H, Wang Z, Li P, Chen Y. Oxygen-deficient black titania for synergistic/enhanced sonodynamic and photoinduced most cancers remedy at close to infrared-II biowindow. ACS Nano. 2018;12(5):4545–55.
Gong F, Cheng L, Yang N, Gong Y, Ni Y, Bai S, Wang X, Chen M, Chen Q, Liu Z. Preparation of TiH(1.924) nanodots by liquid-phase exfoliation for enhanced sonodynamic most cancers remedy. Nat Commun. 2020;11(1):3712.
Qian X, Zheng Y, Chen Y. Micro/nanoparticle-augmented sonodynamic remedy (SDT): breaking the depth shallow of photoactivation. Adv Mater. 2016;28(37):8097–129.
Gong F, Cheng L, Yang N, Betzer O, Feng L, Zhou Q, Li Y, Chen R, Popovtzer R, Liu Z. Ultrasmall oxygen-deficient bimetallic oxide MnWO(X) nanoparticles for depletion of endogenous GSH and enhanced sonodynamic most cancers remedy. Adv Mater. 2019;31(23):e1900730.
Lin X, Music J, Chen X, Yang H. Ultrasound-activated sensitizers and functions. Angewandte Chemie Int Ed Engl. 2020;59(34):14212–33.
Pan X, Bai L, Wang H, Wu Q, Wang H, Liu S, Xu B, Shi X, Liu H. Metallic-organic-framework-derived carbon nanostructure augmented sonodynamic most cancers remedy. Adv Mater. 2018;30(23):e1800180.
Cheng Ok, Sano M, Jenkins CH, Zhang G, Vernekohl D, Zhao W, Wei C, Zhang Y, Zhang Z, Liu Y, Cheng Z, Xing L. Synergistically enhancing the therapeutic impact of radiation remedy with radiation activatable and reactive oxygen species-releasing nanostructures. ACS Nano. 2018;12(5):4946–58.
Luo T, Wang D, Liu L, Zhang Y, Han C, Xie Y, Liu Y, Liang J, Qiu G, Li H, Su D, Liu J, Zhang Ok. Switching reactive oxygen species into reactive nitrogen species by photocleaved O(2)-released nanoplatforms favors hypoxic tumor repression. Adv Sci. 2021;8(19):e2101065.
Pan X, Wang H, Wang S, Solar X, Wang L, Wang W, Shen H, Liu H. Sonodynamic remedy (SDT): a novel technique for most cancers nanotheranostics, Science China. Life Sci. 2018;61(4):415–26.
Li Z, Han J, Yu L, Qian X, Xing H, Lin H, Wu M, Yang T, Chen Y. Synergistic sonodynamic/chemotherapeutic suppression of hepatocellular carcinoma by focused biodegradable mesoporous nanosonosensitizers. Adv Funct Mater. 2018;28(26):18001451–180014516.
Zhang Y, Wang F, Liu C, Wang Z, Kang L, Huang Y, Dong Ok, Ren J, Qu X. Nanozyme embellished metal-organic frameworks for enhanced photodynamic remedy. ACS Nano. 2018;12(1):651–61.
Zheng DW, Li B, Li CX, Fan JX, Lei Q, Li C, Xu Z, Zhang XZ. Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic remedy towards hypoxic tumor through water splitting. ACS Nano. 2016;10(9):8715–22.
Guan X, Yin H-H, Xu X-H, Xu G, Zhang Y, Zhou B-G, Yue W-W, Liu C, Solar L-P, Xu H-X, Zhang Ok. Tumor metabolism-engineered composite nanoplatforms potentiate sonodynamic remedy through reshaping tumor microenvironment and facilitating electron-hole pairs’ separation. Adv Func Mater. 2020;30(27):2000326.
Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal remedy and photoacoustic imaging through nanotheranostics in combating most cancers. Chem Soc Rev. 2019;48(7):2053–108.
Shao W, Chen G, Kuzmin A, Kutscher HL, Pliss A, Ohulchanskyy TY, Prasad PN. Tunable slender band emissions from dye-sensitized core/shell/shell nanocrystals within the second near-infrared organic window. J Am Chem Soc. 2016;138(50):16192–5.
Liu Z, Li J, Chen W, Liu L, Yu F. Gentle and sound to set off the Pandora’s field towards breast most cancers: a mixture technique of sonodynamic, photodynamic and photothermal therapies. Biomaterials. 2020;232:119685.
Gao F, He G, Yin H, Chen J, Liu Y, Lan C, Zhang S, Yang B. Titania-coated 2D gold nanoplates as nanoagents for synergistic photothermal/sonodynamic remedy within the second near-infrared window. Nanoscale. 2019;11(5):2374–84.
Yue W, Chen L, Yu L, Zhou B, Yin H, Ren W, Liu C, Guo L, Zhang Y, Solar L, Zhang Ok, Xu H, Chen Y. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic remedy mixture reduces tumour progress and metastases in mice. Nat Commun. 2019;10(1):2025.
Feng B, Zhou F, Hou B, Wang D, Wang T, Fu Y, Ma Y, Yu H, Li Y. Binary cooperative prodrug nanoparticles enhance immunotherapy by synergistically modulating immune tumor microenvironment. Adv Mater. 2018;30(38):e1803001.
He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum RR, Lin W. Core-shell nanoscale coordination polymers mix chemotherapy and photodynamic remedy to potentiate checkpoint blockade most cancers immunotherapy. Nat Commun. 2016;7:12499.
Riley RS, Day ES. Gold nanoparticle-mediated photothermal remedy: functions and alternatives for multimodal most cancers therapy, Wiley interdisciplinary critiques. Nanomed Nanobiotechnol. 2017;9(4):e1449.
Guo Y, Ran Y, Wang Z, Cheng J, Cao Y, Yang C, Liu F, Ran H. Magnetic-responsive and focused most cancers nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy. Biomaterials. 2019;219:119370.
Chen H, Liu L, Ma A, Yin T, Chen Z, Liang R, Qiu Y, Zheng M, Cai L. Noninvasively immunogenic sonodynamic remedy with manganese protoporphyrin liposomes towards triple-negative breast most cancers. Biomaterials. 2021;269:120639.
Yin Y, Jiang X, Solar L, Li H, Su C, Zhang Y, Xu G, Li X, Zhao C, Chen Y, Xu H, Zhang Ok. Steady inertial cavitation evokes huge ROS for reinforcing sonodynamic remedy and immunogenic cell loss of life towards breast carcinoma. Nano At the moment. 2021;36:101009.
Zhang Q, Bao C, Cai X, Jin L, Solar L, Lang Y, Li L. Sonodynamic therapy-assisted immunotherapy: a novel modality for most cancers therapy. Most cancers Sci. 2018;109(5):1330–45.
Tao Y, Ju E, Ren J, Qu X. Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune most cancers remedy. Biomaterials. 2014;35(37):9963–71.
Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W. Combinatorial photothermal and immuno most cancers remedy utilizing chitosan-coated hole copper sulfide nanoparticles. ACS Nano. 2014;8(6):5670–81.
Li X, Naylor MF, Le H, Nordquist RE, Teague TK, Howard CA, Murray C, Chen WR. Scientific results of in situ photoimmunotherapy on late-stage melanoma sufferers: a preliminary examine. Most cancers Biol Ther. 2010;10(11):1081–7.
Wang X, Zhang W, Xu Z, Luo Y, Mitchell D, Moss RW. Sonodynamic and photodynamic remedy in superior breast carcinoma: a report of three instances. Integr Most cancers Ther. 2009;8(3):283–7.
Inui T, Makita Ok, Miura H, Matsuda A, Kuchiike D, Kubo Ok, Mette M, Uto Y, Nishikata T, Hori H, Sakamoto N. Case report: a breast most cancers affected person handled with GcMAF, sonodynamic remedy and hormone remedy. Anticancer Res. 2014;34(8):4589–93.
Solar CY, Liu Y, Du JZ, Cao ZT, Xu CF, Wang J. Facile technology of tumor-pH-labile linkage-bridged block copolymers for chemotherapeutic supply. Angewandte Chemie Int Ed Eng. 2016;55(3):1010–4.
Solar R, Liu Y, Li SY, Shen S, Du XJ, Xu CF, Cao ZT, Bao Y, Zhu YH, Li YP, Yang XZ, Wang J. Corrigendum to “Co-delivery of all-trans-retinoic acid and doxorubicin for most cancers remedy with synergistic inhibition of most cancers stem cells” [Biomaterials 37 (2015) 405-414]. Biomaterials. 2020;263:120373.
Li F, Li T, Cao W, Wang L, Xu H. Close to-infrared gentle stimuli-responsive synergistic remedy nanoplatforms based mostly on the coordination of tellurium-containing block polymer and cisplatin for most cancers therapy. Biomaterials. 2017;133:208–18.
Li Y, Xu X, Zhang X, Li Y, Zhang Z, Gu Z. Tumor-specific a number of stimuli-activated dendrimeric nanoassemblies with metabolic blockade surmount chemotherapy resistance. ACS Nano. 2017;11(1):416–29.
Wu X, Zhou L, Su Y, Dong CM. Plasmonic, focused, and twin drugs-loaded polypeptide composite nanoparticles for synergistic cocktail chemotherapy with photothermal remedy. Biomacromol. 2016;17(7):2489–501.
Costley D, Mc Ewan C, Fowley C, McHale AP, Atchison J, Nomikou N, Callan JF. Treating most cancers with sonodynamic remedy: a evaluate. Int J Hyperthermia. 2015;31(2):107–17.
Ma A, Chen H, Cui Y, Luo Z, Liang R, Wu Z, Chen Z, Yin T, Ni J, Zheng M, Cai L. Metalloporphyrin complex-based nanosonosensitizers for deep-tissue tumor theranostics by noninvasive sonodynamic remedy. Small. 2019;15(5):e1804028.
Solar H, Su J, Meng Q, Yin Q, Chen L, Gu W, Zhang P, Zhang Z, Yu H, Wang S, Li Y. Most cancers-cell-biomimetic nanoparticles for focused remedy of homotypic tumors. Adv Mater. 2016;28(43):9581–8.
Feng B, Zhou F, Xu Z, Wang T, Wang D, Liu J, Fu Y, Yin Q, Zhang Z, Yu H. Versatile prodrug nanoparticles for acid-triggered exact imaging and organelle-specific mixture most cancers remedy. Adv Funct Mater. 2016;26(41):7431–42.
Solar R, Liu Y, Li SY, Shen S, Du XJ, Xu CF, Cao ZT, Bao Y, Zhu YH, Li YP, Yang XZ, Wang J. Co-delivery of all-trans-retinoic acid and doxorubicin for most cancers remedy with synergistic inhibition of most cancers stem cells. Biomaterials. 2015;37:405–14.
Rao L, Meng QF, Bu LL, Cai B, Huang Q, Solar ZJ, Zhang WF, Li A, Guo SS, Liu W, Wang TH, Zhao XZ. Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces. 2017;9(3):2159–68.
Zhang JJ, Lin Y, Zhou H, He H, Ma JJ, Luo MY, Zhang ZL, Pang DW. Cell membrane-camouflaged NIR II Fluorescent Ag2 Te quantum dots-based nanobioprobes for enhanced in vivo homotypic tumor imaging. Adv Healthc Mater. 2019;8(14):e1900341.
Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic supply platform. Proc Natl Acad Sci USA. 2011;108(27):10980–5.
Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr, van Rooijen N, Weissman IL. CD47 is an hostile prognostic issue and therapeutic antibody goal on human acute myeloid leukemia stem cells. Cell. 2009;138(2):286–99.
Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, Gao G, Pan H, Liu L, Ma A, Cui H, Ma Y, Cai L. Most cancers cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal remedy. ACS Nano. 2016;10(11):10049–57.
Fang RH, Hu CM, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L. Most cancers cell membrane-coated nanoparticles for anticancer vaccination and drug supply. Nano Lett. 2014;14(4):2181–8.
Qiao B, Luo Y, Cheng HB, Ren J, Cao J, Yang C, Liang B, Yang A, Yuan X, Li J, Deng L, Li P, Ran HT, Hao L, Zhou Z, Li M, Zhang Y, Timashev PS, Liang XJ, Wang Z. Synthetic nanotargeted cells with steady photothermal efficiency for multimodal imaging-guided tumor-specific remedy. ACS Nano. 2020;14(10):12652–67.
Rao L, Bu LL, Cai B, Xu JH, Li A, Zhang WF, Solar ZJ, Guo SS, Liu W, Wang TH, Zhao XZ. Most cancers cell membrane-coated upconversion nanoprobes for extremely particular tumor imaging. Adv Mater. 2016;28(18):3460–6.
Xie W, Deng WW, Zan M, Rao L, Yu GT, Zhu DM, Wu WT, Chen B, Ji LW, Chen L, Liu Ok, Guo SS, Huang HM, Zhang WF, Zhao X, Yuan Y, Dong W, Solar ZJ, Liu W. Most cancers cell membrane camouflaged nanoparticles to appreciate hunger remedy along with checkpoint blockades for enhancing most cancers remedy. ACS Nano. 2019;13(3):2849–57.
Zhang N, Li M, Solar X, Jia H, Liu W. NIR-responsive most cancers cytomembrane-cloaked carrier-free nanosystems for extremely environment friendly and self-targeted tumor drug supply. Biomaterials. 2018;159:25–36.
Ledford H. Therapeutic most cancers vaccine survives biotech bust. Nature. 2015;519(7541):17–8.
DeFrancesco L. CAR-T cell remedy seeks methods to harness cytokine storm. Nat Biotechnol. 2014;32(7):604.
Ludin A, Zon LI. Most cancers immunotherapy: the darkish facet of PD-1 receptor inhibition. Nature. 2017;552(7683):41–2.
Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen Ok, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, Şenbabaoğlu Y, Santoro S, Sheinson D, Hung J, Giltnane JM, Pierce AA, Mesh Ok, Lianoglou S, Riegler J, Carano RAD, Eriksson P, Höglund M, Somarriba L, Halligan DL, van der Heijden MS, Loriot Y, Rosenberg JE, Fong L, Mellman I, Chen DS, Inexperienced M, Derleth C, High quality GD, Hegde PS, Bourgon R, Powles T. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544–8.
Gajewski TF, Woo SR, Zha Y, Spaapen R, Zheng Y, Corrales L, Spranger S. Most cancers immunotherapy methods based mostly on overcoming limitations throughout the tumor microenvironment. Curr Opin Immunol. 2013;25(2):268–76.
Hegde PS, Karanikas V, Evers S. The the place, the when, and the how of immune monitoring for most cancers immunotherapies within the period of checkpoint inhibition. Clin Most cancers Res. 2016;22(8):1865–74.
Sabado RL, Bhardwaj N. Most cancers immunotherapy: dendritic-cell vaccines on the transfer. Nature. 2015;519(7543):300–1.
Makuku R, Khalili N, Razi S, Keshavarz-Fathi M, Rezaei N. Present and future views of PD-1/PDL-1 blockade in most cancers immunotherapy. J Immunol Res. 2021;2021:6661406.
Mei H, Zhang X, Cai S, Zhang X, Zhang Y, Guo Z, Shi W, Chu R, Zhang Ok, Cao J, He B. Fluorocarbon-driven photosensitizer meeting decodes vitality conversion pathway for suppressing breast tumor. Nano At the moment. 2021;41:101305.
Huang J, Liu F, Han X, Zhang L, Hu Z, Jiang Q, Wang Z, Ran H, Wang D, Li P. Nanosonosensitizers for extremely environment friendly sonodynamic most cancers theranostics. Theranostics. 2018;8(22):6178–94.
Lei TC, Glazner GF, Duffy M, Scherrer L, Pendyala S, Li B, Wang X, Wang H, Huang Z. Optical properties of hematoporphyrin monomethyl ether (HMME), a PDT photosensitizer. Photodiagn Photodyn Ther. 2012;9(3):232–42.
Liu T, Zhang M, Liu W, Zeng X, Music X, Yang X, Zhang X, Feng J. Metallic Ion/Tannic acid meeting as a flexible photothermal platform in engineering multimodal nanotheranostics for superior functions. ACS Nano. 2018;12(4):3917–27.
Sungur S, Uzar A. Investigation of complexes tannic acid and myricetin with Fe(III), Spectrochimica acta. Half A, Mol Biomol Spectrosc. 2008;69(1):225–9.
Wang B, He X, Zhang Z, Zhao Y, Feng W. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res. 2013;46(3):761–9.
Liu Z, Davis C, Cai W, He L, Chen X, Dai H. Circulation and long-term destiny of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA. 2008;105(5):1410–5.
Shi J, Chen Z, Wang B, Wang L, Lu T, Zhang Z. Reactive oxygen species-manipulated drug launch from a wise envelope-type mesoporous titanium nanovehicle for tumor sonodynamic-chemotherapy. ACS Appl Mater Interfaces. 2015;7(51):28554–65.
Sivakumar B, Aswathy RG, Romero-Aburto R, Mitcham T, Mitchel KA, Nagaoka Y, Bouchard RR, Ajayan PM, Maekawa T, Sakthikumar DN. Extremely versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of most cancers cells and as multimodal imaging brokers. Biomater Sci. 2017;5(3):432–43.
Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, Dawson NA, van der Heijden MS, Dreicer R, Srinivas S, Retz MM, Joseph RW, Drakaki A, Vaishampayan UN, Sridhar SS, Quinn DI, Durán I, Shaffer DR, Eigl BJ, Grivas PD, Yu EY, Li S, Kadel EE third, Boyd Z, Bourgon R, Hegde PS, Mariathasan S, Thåström A, Abidoye OO, High quality GD, Bajorin DF. Atezolizumab as first-line therapy in cisplatin-ineligible sufferers with domestically superior and metastatic urothelial carcinoma: a single-arm, multicentre, section 2 trial. Lancet. 2017;389(10064):67–76.
Pommier A, Anaparthy N, Memos N, Kelley ZL, Gouronnec A, Yan R, Auffray C, Albrengues J, Egeblad M, Iacobuzio-Donahue CA, Lyons SK, Fearon DT. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic most cancers metastases. Science. 2018;360(6394):eaao4908.
Mellman I, Coukos G, Dranoff G. Most cancers immunotherapy comes of age. Nature. 2011;480(7378):480–9.
Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006;6(6):476–83.
Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour community: myeloid-derived suppressor cells, regulatory T cells and pure killer T cells. Immunology. 2013;138(2):105–15.
